Distúrbio peroxissomal que resulta em desmielinização cerebral, disfunção axonal na medula espinhal levando a paraplegia espástica, insuficiência adrenal e, em alguns casos, insuficiência testicular.
Introdução
O que você precisa saber de cara
Distúrbio peroxissomal que resulta em desmielinização cerebral, disfunção axonal na medula espinhal levando a paraplegia espástica, insuficiência adrenal e, em alguns casos, insuficiência testicular.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 64 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 133 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: X-linked dominant.
ATP-dependent transporter of the ATP-binding cassette (ABC) family involved in the transport of very long chain fatty acid (VLCFA)-CoA from the cytosol to the peroxisome lumen (PubMed:11248239, PubMed:15682271, PubMed:16946495, PubMed:18757502, PubMed:21145416, PubMed:23671276, PubMed:29397936, PubMed:33500543). Coupled to the ATP-dependent transporter activity also has a fatty acyl-CoA thioesterase activity (ACOT) and hydrolyzes VLCFA-CoA into VLCFA prior their ATP-dependent transport into pero
Peroxisome membraneMitochondrion membraneLysosome membraneEndoplasmic reticulum membrane
Adrenoleukodystrophy
A peroxisomal metabolic disorder characterized by progressive multifocal demyelination of the central nervous system and by peripheral adrenal insufficiency (Addison disease). It results in mental deterioration, corticospinal tract dysfunction, and cortical blindness. Different clinical manifestations exist like: cerebral childhood ALD (CALD), adult cerebral ALD (ACALD), adrenomyeloneuropathy (AMN) and 'Addison disease only' (ADO) phenotype.
Medicamentos e terapias
Mecanismo: Peroxisome proliferator-activated receptor gamma agonist
Mecanismo: Peroxisome proliferator-activated receptor gamma agonist
Variantes genéticas (ClinVar)
945 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
6 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Adrenoleucodistrofia ligada ao X
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
9 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
74 ensaios clínicos encontrados, 12 ativos.
Publicações mais relevantes
Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X-Linked Adrenoleukodystrophy.
X-linked adrenoleukodystrophy (X-ALD) is a rare monogenic disorder characterized by marked variability in clinical presentation, age at onset, and disease progression. A deeper understanding of its natural history and the relationship between biochemical markers and clinical phenotypes is essential for improving disease monitoring, patient counseling, and optimizing clinical trial design. In particular, the predictive value of very long-chain fatty acids (VLCFA) for clinical phenotypes has recently garnered increased attention. In this longitudinal, mixed prospective/retrospective, single-center study, we analyzed clinical and biochemical data from 364 patients with X-ALD (255 males). Parameters included clinical scores (EDSS, AACS), age at symptom onset, and disease manifestations, which were correlated with individual VLCFA levels. Patients with adrenal insufficiency (AI) exhibited significantly elevated VLCFA concentrations. Higher C26:0 levels were associated with faster progression (measured by EDSS); however, effect sizes were small and inter-individual variability considerable. Although initial symptom severity was comparable between sexes, males presented earlier and progressed faster. Among patients seen in early clinical stages (EDSS ≤ 4.5), disease progression rates were higher (males: 0.34 ± 0.77; females: 0.11 ± 0.11) than in those presenting at more advanced stages (EDSS > 4.5; males: 0.23 ± 0.33; females: 0.09 ± 0.10). We provide comprehensive data on the prevalence of disease manifestations and the natural course of X-ALD in a large adult cohort. The observed association between elevated VLCFA levels and adrenal insufficiency should be considered in future clinical monitoring and trial design. However, due to the small effect sizes and variability, VLCFA levels offer limited prognostic utility for individual patients.
Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.
Peroxisomes are dynamic organelles that play a crucial role in cellular metabolism, particularly in fatty acid degradation, cholesterol homeostasis and reactive oxygen species metabolism. Their dysfunction is associated with severe neurological disorders, including Zellweger spectrum disorders (ZSD) and X-linked adrenoleukodystrophy (X-ALD). In this study, we investigated the relationship between cholesterol homeostasis and myelination in postnatal peroxisome-deficient Pex2 knockout mice. We dissected the central nervous system (CNS) of 10-day-old (P10) control and Pex2 -/- mice into five regions: spinal cord, brainstem, cerebellum, diencephalon and cerebral cortex. Catalase activity, a marker enzyme of peroxisomes, was significantly increased in CNS regions of Pex2 -/- mice, indicating an oxidative imbalance. Proteomic analysis revealed significant alterations in peroxisomal proteins and pathways related to neurodegenerative diseases, cholesterol and fatty acid metabolism and mRNA processing. Cholesterol biosynthesis was particularly dysregulated: enzyme activities, mRNA, and protein levels were reduced in white matter regions but increased in the cerebral cortex. The elevated desmosterol levels in the brain of Pex2 -/- mice indicate impaired cholesterol synthesis. Sphingolipid metabolism was also altered in the peroxisome-deficient CNS, as the protein levels of enzymes dihydroceramide desaturase 1, ceramide synthase 2, fatty acid 2-hydroxylase, and UDP-glycosyltransferase 8 were significantly decreased. Myelination was significantly reduced throughout the CNS, as evidenced by decreased activities of the myelin marker 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and decreased mRNA and protein levels of myelin-associated proteins. The consistent decrease in ribosomal protein S6 phosphorylation in the CNS of Pex2 -/- mice suggests that decreased mechanistic target of rapamycin complex 1 (mTORC1) activity contributes to hypomyelination. Gene expression analysis revealed an upregulation of pro-inflammatory cytokines and altered expression of some homeostatic and disease-associated microglial (DAM) genes. However, full DAM activation was not yet observed in Pex2 -/- mice at P10. In conclusion, this study shows that systemic peroxisome deficiency leads to severe hypomyelination and dysregulation of cholesterol and fatty acid metabolism in the CNS, providing new insights into the pathophysiology of peroxisomal disorders.
The Grey Zone Project: Risk-Based Classification of ABCD1 Variants in X-Linked Adrenoleukodystrophy.
Newborn screening (NBS) for X-linked adrenoleukodystrophy (ALD) enables early identification of boys at risk for adrenal insufficiency (AI) and cerebral ALD (CALD). However, NBS frequently identifies ABCD1 variants of uncertain significance (VUS), which are associated with only borderline-elevated C26:0-lysophosphatidylcholine (LPC(26:0)) levels. Traditional American College of Medical Genetics and Genomics (ACMG) pathogenicity classification does not account for age-dependent penetrance or the broader phenotypic spectrum, complicating risk assessment and clinical management. Through the Grey Zone Project, we developed a risk-stratification framework using a receiver operating characteristic (ROC)-based approach prioritizing 95% sensitivity. This framework incorporates biochemical and longitudinal clinical data from 1627 control subjects and 196 confirmed ALD patients. Three pediatric risk categories were defined: "no ALD" (<110 nmol/L LPC(26:0)), "lower-risk AI/CALD" (110-177 nmol/L), and "at-risk AI/CALD" (>177 nmol/L). When applied to 108 samples carrying 51 unique ABCD1 VUSs, 26 variants were reclassified as "no ALD," 15 as "lower-risk AI/CALD," and 10 as "at-risk AI/CALD." The framework reclassifies ABCD1 variants based on biochemical risk profiles, reducing false-positive referrals, avoiding unnecessary MRI surveillance, and alleviating parental anxiety by identifying children who are unlikely to develop childhood-onset disease. Integrating biochemical thresholds with genetic and longitudinal clinical data improves the specificity of NBS without compromising its sensitivity. Providing systematic feedback on false-positive cases to screening laboratories will further refine cut-offs. This framework provides a scalable, evidence-based model for interpreting variants and enabling personalized follow-up in ALD and other disorders with a variable age of onset.
[Status and prospects for neonatal screening of X-linked adrenoleukodystrophy].
儿童期脑型X连锁肾上腺脑白质营养不良(X-ALD)是高致死性神经系统白质疾病,如不早期诊治,常发病5~10年死亡,新生儿筛查对于早期诊治具有重要意义。部分国家或地区已通过检测极长链脂肪酸开展X-ALD新生儿筛查。国内新一代串联质谱检测试剂盒新增X-ALD筛查指标,为X-ALD新生儿筛查提供了有力支撑,但仍面临一些问题。本文就我国X-ALD新生儿筛查现状进行论述,以期促进全民健康。.
Evolution of the lipidome uncovers early changes in adrenoleukodystrophy human cortical and spinal organoids.
Lipids are critical for the structure, signaling, and metabolism of the central nervous system (CNS), yet their roles during human brain development remain underexplored due to limited tissue availability. X-linked adrenoleukodystrophy (ALD), a peroxisomal disorder caused by ABCD1 mutations, disrupts very long-chain fatty acid (VLCFA) degradation, leading to axonal degeneration and demyelination. To investigate lipid dynamics in CNS development and ALD pathogenesis, we generated human induced pluripotent stem cell (hiPSC)-derived cortical and spinal cord organoids and performed lipidomics over 200 days. Lipidomic analysis revealed a dynamic lipidome, with changes in lipid abundance, saturation, and chain length reflecting neurodevelopment. ALD hiPSC-derived organoids exhibited significant lipid alterations over time, including elevated VLCFA levels and reductions in brain-relevant lipids, such as sulfatides and gangliosides, in cortical organoids. These findings provide a foundational resource for studying lipid dynamics in CNS development and emphasize the value of organoids for understanding ALD and other CNS diseases.
Publicações recentes
Pediatric X-linked adrenoleukodystrophy: phenotypes, variants, and HSCT outcomes.
Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy.
Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD-Related Myelopathy.
X-linked adrenoleukodystrophy as an etiological cause of progressive spastic paraplegia: A case report.
Pretreatment blood NfL indicates response to cellular therapies in cerebral adrenoleukodystrophy.
📚 EuropePMC685 artigos no totalmostrando 195
X-linked adrenoleukodystrophy as an etiological cause of progressive spastic paraplegia: A case report.
The Journal of international medical researchPretreatment blood NfL indicates response to cellular therapies in cerebral adrenoleukodystrophy.
Communications medicineNatural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X-Linked Adrenoleukodystrophy.
Journal of inherited metabolic diseaseDysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.
Frontiers in molecular neurosciencePrimary Adrenal Insufficiency in Pseudo-Neonatal Adrenoleukodystrophy Case Report.
Journal of clinical research in pediatric endocrinologyThe Grey Zone Project: Risk-Based Classification of ABCD1 Variants in X-Linked Adrenoleukodystrophy.
Journal of inherited metabolic diseaseLate-Onset X-linked Adrenoleukodystrophy: A Rare Cause of Progressive Spastic Paraparesis.
CureusCongenital Inborn Errors of Metabolism: Clinical and Imaging Pearls.
Radiographics : a review publication of the Radiological Society of North America, Inc[Status and prospects for neonatal screening of X-linked adrenoleukodystrophy].
Zhonghua er ke za zhi = Chinese journal of pediatricsEvolution of the lipidome uncovers early changes in adrenoleukodystrophy human cortical and spinal organoids.
iSciencePhosphatidylcholine with C26:0 moiety, a precursor of a diagnostic marker for X-ALD, is synthesized by LPLAT10/LPEAT2.
Journal of lipid researchNew multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.
Journal of lipid researchAn AAV-Based Therapy Approach for Neurological Phenotypes of X-Linked Adrenoleukodystrophy.
International journal of molecular sciencesAdult onset cerebral adrenoleukodystrophy: report of an atypical case.
Acta neurologica BelgicaSexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X-Linked Adrenoleukodystrophy.
Journal of inherited metabolic diseaseMonogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults: An Evolving Landscape.
Neurology. GeneticsA Qualitative Study on Parental Experiences with Genetic Counseling After a Positive Newborn Screen for Recently Added Conditions on the Recommended Uniform Screening Panel (RUSP).
International journal of neonatal screeningX-Linked Adrenoleukodystrophy in a Moroccan Patient: Genetic Diagnosis Leads to Presymptomatic Testing and Family Counseling.
Balkan journal of medical genetics : BJMGNovel ABCD1 splice site mutation causing adult-onset X-linked adrenoleukodystrophy with predominant dysarthria.
Internal medicine journalMitochondrial dysfunction and impaired oxidative stress defense as potential trigger of cerebral X-linked adrenoleukodystrophy.
Free radical biology & medicineNationwide Study of the Epidemiology and Clinical Features of X-Linked Adrenoleukodystrophy in Denmark.
Molecular genetics and metabolismNeuroregenerative Treatment With Radio Electric Asymmetric Conveyer Technology in Advanced Childhood Cerebral X-linked Adrenoleukodystrophy: Clinical Stabilization and Electroencephalographic Evidence of Cortico-Subcortical Reorganization.
CureusDifferentiating Incidental From Pathologic Brain MRI Findings in Asymptomatic Boys With X-Linked Adrenoleukodystrophy: A Multicenter Study.
NeurologyAn Automated Analysis Tool for Diffusion Tensor Imaging-Based Quantitative MRI in X-Linked Adrenoleukodystrophy.
Journal of inherited metabolic diseaseNewborn Screening of X-Linked Adrenoleukodystrophy in Italy: Clinical and Biochemical Outcomes from a 4-Year Pilot Study.
International journal of neonatal screeningHypogonadism in adult males with adrenoleukodystrophy.
Annales d'endocrinologieClinical and radiological characteristics of adult-onset X-linked adrenoleukodystrophy: a Chinese cohort study and review of the literature.
BMC neurologyMyelin-water imaging and multi-shell diffusion-weighted imaging in adults with adrenoleukodystrophy.
Brain communicationsA Novel Missense Variant of the ABCD1 Gene in X-Linked Adrenoleukodystrophy in Chinese Family.
Molecular genetics & genomic medicineImproving quality of life in rare diseases using disease-specific, multidisciplinary online interventions on the example of rare X-linked adrenoleukodystrophy: a randomized-controlled trial.
Therapeutic advances in neurological disordersOptimization of the Performance of Newborn Screening for X-Linked Adrenoleukodystrophy by Flow Injection Analysis Tandem Mass Spectrometry.
International journal of neonatal screening[Two cases of X-linked adrenoleukodystrophy presenting with Addison's disease as the initial manifestation and analysis of novel ABCD1 variants].
Zhonghua nei ke za zhiPeripheral nerve enlargement and hyperechogenicity in patients with X-linked adrenoleukodystrophy using high-resolution ultrasound.
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyCase Report: Incidental diagnosis of cystic fibrosis via whole genome sequencing alters HSCT planning in a child with cerebral X-linked adrenoleukodystrophy.
Frontiers in pediatricsIncidental diagnosis of primary adrenal insufficiency precipitated by positive ABCD1 gene mutation detected on cascade screening.
BMJ case reportsBridging Equity Gaps in Newborn Screening: Reflections on X-Linked Adrenoleukodystrophy (X-ALD) and Policy Implications for the Global South.
Journal of primary care & community healthCost-Effectiveness of Newborn Screening for X-Linked Adrenoleukodystrophy in the Netherlands: A Health-Economic Modelling Study.
International journal of neonatal screeningInflammation and Immunomodulation in Cerebral X-linked Adrenoleukodystrophy: Review of Pathology and Interventions.
Journal of child neurologyTeaching NeuroImage: X-Linked Adrenoleukodystrophy With Rare Temporal Pole Involvement.
NeurologyClinical Variation and Neuroimaging Patterns in Monozygotic Twins With Arrested X-Linked Adrenoleukodystrophy: A Case Report.
CureusBeyond newborn screening: the role of reverse cascade testing in familial disease detection.
Critical reviews in clinical laboratory sciencesOverview of genetic mutations causing adrenoleukodystrophy: A case-series study.
Molecular genetics and metabolism reportsClinical Vigilance in Rare Disease Management: Atypical Features Lead to Discovery of Concurrent X-linked Adrenoleukodystrophy and Cystic Fibrosis.
Journal of child neurologyPerceptions and Experiences of Families of Infants Diagnosed with X-Linked Adrenoleukodystrophy (X-ALD) via Newborn Screening in Georgia and Kentucky.
Journal of primary care & community healthTwenty years of misdiagnosis of X-linked adrenoleukodystrophy: a case report.
American journal of translational researchSafety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial.
EClinicalMedicineSeizures in childhood cerebral adrenoleukodystrophy.
Developmental medicine and child neurologyRevisiting the Pathogenesis of X-Linked Adrenoleukodystrophy.
GenesUnraveling X-linked adrenoleukodystrophy in women: a rare case of central nervous system manifestations and implications for screening.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyNervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts.
British journal of pharmacology[A clinical case of X-linked adrenoleukodystrophy].
Zhurnal nevrologii i psikhiatrii imeni S.S. KorsakovaMosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing.
NPJ genomic medicineBlood Biomarkers Reflecting Brain Pathology-From Common Grounds to Rare Frontiers.
Journal of inherited metabolic diseaseHome-Based Rehabilitation With Frenkel's Exercises for Adrenomyeloneuropathy: A Case Report.
CureusAdult-onset cerebral X-linked adrenoleukodystrophy presenting with frontal lobe syndrome caused by a de novo ABCD1 gene mutation (c.1415_1416delAG, p.Gln472fs*83).
Neurology perspectivesNovel ABCD1 Variants in X-Linked Adrenoleukodystrophy.
Clinical geneticsDentate calcifications with palatal tremor and facial myorhythmia in adult-onset cerebral X-linked adrenoleukodystrophy: Expert commentary Marcelo Kauffman, MD, PhD.
Parkinsonism & related disordersReporting ABCD1 variants as actionable secondary findings on exome and genome sequencing.
Genetics in medicine : official journal of the American College of Medical GeneticsIncidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study.
Orphanet journal of rare diseasesGenotypic and Phenotypic Characteristics of Pediatric X-Adrenoleukodystrophy in a Chinese Cohort.
Neuropsychiatric disease and treatmentDevelopment of a rabbit model for adrenoleukodystrophy: A pilot study on gene therapy using rAAV9.
Molecular therapy. Nucleic acidsGeneration and Characterization of Human iPSC-Derived Astrocytes with Potential for Modeling X-Linked Adrenoleukodystrophy Phenotypes.
International journal of molecular sciencesNewborn screening and rapid genomic diagnosis of neuromuscular diseases.
Journal of neuromuscular diseasesDentate calcifications with palatal tremor and facial myorhythmia in adult-onset Cerebral X-linked Adrenoleukodystrophy.
Parkinsonism & related disordersImpaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes.
Frontiers in molecular neuroscienceDisease Burden in Female Patients With X-Linked Adrenoleukodystrophy.
NeurologyPrimary adrenal insufficiency in children excluding congenital adrenal hyperplasia: insights from 33-year single-center experience in Tunisia.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrieHematopoietic stem cell transplantation in inborn errors of metabolism-a retrospective analysis on behalf of the pediatric disease working party from the Brazilian Society of Bone Marrow Transplantation and Cellular Therapy.
Bone marrow transplantationWhole exome sequencing reveals ABCD1 variant as a potential contributor to male infertility.
Molecular biology reportsOptical coherence tomography angiography reveals abnormal retinal vascular density and perfusion in patients with X-linked adrenoleukodystrophy: a cross-sectional study.
Orphanet journal of rare diseasesInsights From Minnesota on Newborn Screening for Adrenoleukodystrophy: A 5-Year Update.
American journal of medical genetics. Part AAltered lipid profile and reduced neuronal support in human induced pluripotent stem cell-derived astrocytes from adrenoleukodystrophy patients.
Journal of inherited metabolic diseaseElivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).
Genetics in medicine openEmerging Role of Ubiquitin Proteasome System and Autophagy in Pediatric Demyelinating Leukodystrophies and Therapeutic Opportunity.
CellsPsychological Impact of Presymptomatic X-Linked ALD Diagnosis and Surveillance: A Small Qualitative Study of Patient and Parent Experiences.
International journal of neonatal screeningFunctional Recovery in a Child With Adrenoleukodystrophy Following Neuroregenerative Effects of Radio Electric Asymmetric Conveyer (REAC) Neuro-Regenerative (RGN-N) Treatment: A Detailed Case Report.
CureusTeaching NeuroImage: Prognostication of X-Linked Adrenoleukodystrophy Based on the Loes Neuroimaging Score.
NeurologyStearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders.
Molecular neurodegenerationFrom gene to therapy: a review of deciphering the role of ABCD1 in combating X-Linked adrenoleukodystrophy.
Lipids in health and diseasePromises and challenges of genomic newborn screening (NBS) - lessons from public health NBS programs.
Pediatric researchPrimary adrenal insufficiency: case study IN 5 tertiary hospitals.
Anales de pediatriaA Novel Mouse Model for Cerebral Inflammatory Demyelination in X-Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets.
Annals of neurologyRole of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model.
CellsA case of X-Linked adrenoleukodystrophy caused by a novel mutation with singular clinical manifestation: unilateral lower limb weakness.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyA case of adrenomyeloneuropathy caused by a novel point mutation in the ABCD1 gene and functional verification.
Frontiers in geneticsGenetic analysis of the X-linked Adrenoleukodystrophy ABCD1 gene in Drosophila uncovers a role in Peroxisomal dynamics.
bioRxiv : the preprint server for biologyLentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.
The New England journal of medicinePractical Approach to Longitudinal Neurologic Care of Adults With X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy.
Neurology. GeneticsPeroxisomal leukodystrophy.
Handbook of clinical neurologyAtaluren-mediated nonsense variant readthrough in D-bifunctional protein deficiency: A case report.
Molecular genetics and metabolism reportsGene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsLipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy.
Communications medicineA female adult-onset X-ALD patient with pure cerebellar symptoms:a case report.
HeliyonInnovative tree-based method for sampling molecular conformations: exploring the ATP-binding cassette subfamily D member 1 (ABCD1) transporter as a case study.
Frontiers in molecular biosciencesHematopoietic stem cell therapy and ex vivo gene therapy for X-linked adrenoleukodystrophy.
Handbook of clinical neurology[Adrenal insufficiency as part of X-linked adrenoleukodystrophy].
Problemy endokrinologiiNewborn Screening for X-Linked Adrenoleukodystrophy (X-ALD): Biochemical, Molecular, and Clinical Characteristics of Other Genetic Conditions.
GenesPathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms.
Journal of biotechnology and biomedicineBrainstem dominant form of X-linked adrenoleukodystrophy with a novel ABCD1 missense variant: A case report and literature review.
Molecular genetics & genomic medicineBurden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study.
Orphanet journal of rare diseasesNephrotic syndrome and adrenoleukodystrophy in a 5-year-old boy.
Pediatric nephrology (Berlin, Germany)Easily misdiagnosed X-linked adrenoleukodystrophy.
Italian journal of pediatricsChildhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening.
Degenerative neurological and neuromuscular diseaseGenerating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.
bioRxiv : the preprint server for biologyLeriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy.
Brain : a journal of neurologyIn vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model.
Molecular therapy : the journal of the American Society of Gene TherapyFour-dimensional lipidomics profiling in X-linked adrenoleukodystrophy using trapped ion mobility mass spectrometry.
Journal of lipid researchInternational validation of meaningfulness of postural sway and gait to assess myeloneuropathy in adults with adrenoleukodystrophy.
Journal of inherited metabolic diseaseImbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy.
Brain : a journal of neurologyX-linked adrenoleukodystrophy in a child.
QJM : monthly journal of the Association of PhysiciansA novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report.
MedicineHaploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X-linked adrenal cerebral leukodystrophy.
Pediatric transplantationCentral precocious puberty in a boy with X-linked adrenoleukodystrophy caused by a novel ABCD1 mutation.
HeliyonThe pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology.
Orphanet journal of rare diseasesCorrigendum: Newborn screening for X-linked adrenoleukodystrophy in Italy: diagnostic algorithm and disease monitoring.
Frontiers in neurologyCurrent Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches.
International journal of molecular sciencesIDH-mutant astrocytoma arising from a demyelinating plaque in a child with X-linked adrenoleukodystrophy.
Journal of neuropathology and experimental neurologyLeukodystrophy Imaging: Insights for Diagnostic Dilemmas.
Medical sciences (Basel, Switzerland)The Clinical Spectrum of Adrenoleukodystrophy at a Portuguese Tertiary Hospital: Case Series and Review of Literature.
CureusPlasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Journal of lipid researchEtiologic Spectrum of Pediatric-Onset Leukodystrophies and Genetic Leukoencephalopathies: The Five-Year Experience of a Tertiary Care Center in Southern India.
Pediatric neurologyNovel ABCD1 variant causes phenotype of adrenomyeloneuropathy with cerebral involvement in Ukrainian siblings: first adult hematopoietic stem cell transplantation for ALD in Ukraine: a case report.
Journal of medical case reportsProgress in leukodystrophies with zebrafish.
Development, growth & differentiationAdrenomyeloneuropathy manifesting as adrenal insufficiency and bilateral lower extremity spastic paraplegia: A case report and literature review.
MedicineGeneration of induced pluripotent stem line (MIPTi001-A) derived from patient with X-linked adrenoleukodystrophy (X-ALD).
Stem cell researchImmune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation.
Frontiers in molecular neuroscienceIncreased neurotoxicity of high-density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very-long-chain fatty acid transporter Abcd1.
Journal of inherited metabolic diseaseEfficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders.
BiomoleculesIPSC-Derived Astrocytes to Model Neuroinflammatory and Metabolic Responses in X-linked Adrenoleukodystrophy.
Journal of biotechnology and biomedicineRole of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans.
Annals of neurologyMagnetic resonance imaging enhancement of spinal nerve roots in a boy with X-linked adrenoleukodystrophy before diagnosis of chronic inflammatory demyelinating polyneuropathy.
Radiology case reportsGene therapy for neurodegenerative disorders in children: dreams and realities.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrieX-linked adrenoleukodystrophy and primary adrenal insufficiency.
Frontiers in endocrinologyGene and Cellular Therapies for Leukodystrophies.
PharmaceuticsDiagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective.
International journal of neonatal screeningA novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis.
bioRxiv : the preprint server for biologyNewborn screening for adrenoleukodystrophy: International experiences and challenges.
Molecular genetics and metabolismA pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Clinica chimica acta; international journal of clinical chemistryAbnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy.
Orphanet journal of rare diseasesGeneration and characterization of induced pluripotent stem cell lines derived from skin fibroblasts of patients with adrenoleukodystrophy.
Stem cell researchMolecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy.
The journal of medical investigation : JMIX-linked cerebral adrenoleukodystrophy.
BMJ case reportsA patient with X-linked adrenoleukodystrophy presenting with central precocious puberty: a case report.
EndocrineABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
BiomoleculesAttitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening.
International journal of neonatal screeningInterstitial lung disease and pancreatic exocrine insufficiency in CADDS: Phenotypic expansion and literature review.
JIMD reportsBiomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.
EBioMedicineSystem-based integrated metabolomics and microRNA analysis identifies potential molecular alterations in human X-linked cerebral adrenoleukodystrophy brain.
Human molecular geneticsVUS: Variant of uncertain significance or very unclear situation?
Molecular genetics and metabolismDicarboxylic acylcarnitine biomarkers in peroxisome biogenesis disorders.
Molecular genetics and metabolismChildhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study.
Orphanet journal of rare diseasesExploratory study of autophagy inducer sirolimus for childhood cerebral adrenoleukodystrophy.
Frontiers in pediatricsClinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series.
Endocrinologia, diabetes y nutricionCerebral X-linked Adrenoleukodystrophy Presenting As Enlarging Cavum Vergae Cyst: A Case Report.
CureusAbcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Acta neuropathologica communicationsVitamin D status and latitude predict brain lesions in adrenoleukodystrophy.
Annals of the Child Neurology SocietyInitial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy.
Acta neurologica BelgicaMultivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
Orphanet journal of rare diseasesPeroxisomal defects in microglial cells induce a disease-associated microglial signature.
Frontiers in molecular neuroscienceImplementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.
International journal of neonatal screeningA Phase 1 Study of Oral Vitamin D3 in Boys and Young Men With X-Linked Adrenoleukodystrophy.
Neurology. GeneticsTwin Premature Infants With Riboflavin and Biotin Deficiency Presenting With Refractory Lactic Acidosis, Rash, and Multiorgan Failure During Prolonged Parenteral Nutrition.
Journal of investigative medicine high impact case reportsNutritional status of children affected by X-linked adrenoleukodystrophy.
Journal of human nutrition and dietetics : the official journal of the British Dietetic AssociationTwo Single Nucleotide Deletions in the ABCD1 Gene Causing Distinct Phenotypes of X-Linked Adrenoleukodystrophy.
International journal of molecular sciencesLysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin.
Science China. Life sciencesEffect of vitamin D supplementation on cerebral blood flow in male patients with adrenoleukodystrophy.
Journal of neuroscience researchNovel mutations in the ABCD1 gene caused adrenomyeloneuropathy in the Chinese population.
Frontiers in neurologyComputational insight into structural basis of human ELOVL1 inhibition.
Computers in biology and medicineNeonatal lupus is a novel cause of positive newborn screening for X-linked adrenoleukodystrophy.
American journal of medical genetics. Part AStructural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.
Signal transduction and targeted therapySelf-reported quality of life in symptomatic and asymptomatic women with X-linked adrenoleukodystrophy.
Brain and behaviorNewborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
Frontiers in neurologyAge and gender-specific reference intervals for a panel of lysophosphatidylcholines estimated by tandem mass spectrometry in dried blood spots.
Practical laboratory medicineSaturated very long-chain fatty acids regulate macrophage plasticity and invasiveness.
Journal of neuroinflammationNeurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening.
Journal of inherited metabolic diseaseEarly recognition of patients with leukodystrophies.
Current problems in pediatric and adolescent health careCerebello-brainstem dominant form of X-linked adrenoleukodystrophy with intrafamilial phenotypic variability.
Frontiers in neurologyParental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders.
International journal of neonatal screeningDiagnosis, treatment and genetic analysis of a case of skin hyperpigmentation as the only manifestation with X-linked adrenoleukodystrophy.
Yi chuan = HereditasStructural and functional insights of the human peroxisomal ABC transporter ALDP.
eLifeAn update on the diagnosis and treatment of adrenoleukodystrophy.
Current opinion in endocrinology, diabetes, and obesityAntioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts.
Antioxidants (Basel, Switzerland)Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy.
Biological & pharmaceutical bulletinSex-specific newborn screening for X-linked adrenoleukodystrophy.
Journal of inherited metabolic disease[Inborn error of metabolism and allogenic hematopoietic cell transplantation: Guidelines from the SFGM-TC].
Bulletin du cancerTargeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsRole of MRI in X-linked adrenoleukodystrophy-A case report.
Radiology case reportsQuantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Methods in molecular biology (Clifton, N.J.)Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Methods in molecular biology (Clifton, N.J.)Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response.
Communications biologySpectrum of Clinical and Imaging Characteristics of 48 X-Linked Adrenoleukodystrophy Patients: Our Experience from a University Hospital.
Neurology IndiaHigh incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
Molecular genetics and metabolism reportsX-linked adrenoleukodystrophy caused by maternal ABCD1 mutation and paternal X chromosome inactivation.
Experimental and therapeutic medicineThe White Matter Rounds experience: The importance of a multidisciplinary network to accelerate the diagnostic process for adult patients with rare white matter disorders.
Frontiers in neurologyThe physiological functions of human peroxisomes.
Physiological reviewsAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Associação brasileira dedicada a Adrenoleucodistrofia.
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Adrenoleucodistrofia ligada ao X
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X-Linked Adrenoleukodystrophy.
- Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.
- The Grey Zone Project: Risk-Based Classification of ABCD1 Variants in X-Linked Adrenoleukodystrophy.
- [Status and prospects for neonatal screening of X-linked adrenoleukodystrophy].
- Evolution of the lipidome uncovers early changes in adrenoleukodystrophy human cortical and spinal organoids.
- Pediatric X-linked adrenoleukodystrophy: phenotypes, variants, and HSCT outcomes.
- Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy.
- Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD-Related Myelopathy.
- X-linked adrenoleukodystrophy as an etiological cause of progressive spastic paraplegia: A case report.
- Pretreatment blood NfL indicates response to cellular therapies in cerebral adrenoleukodystrophy.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:43(Orphanet)
- OMIM OMIM:300100(OMIM)
- MONDO:0018544(MONDO)
- GARD:5758(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q366964(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
